Ciprofloxacin-induced QTc prolongation

Journal of Association of Physicians of India

Volumn 50, Issue 3, 2002, Pages 430-431

  Singh, H ^a   Kishore, K ^a   Gupta, M S ^a   Khetarpal, S ^a   Jain, S ^a   Mangla, M ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN;

ADULT; ARTICLE; CARDIOVERSION; CASE REPORT; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HEART VENTRICLE TACHYCARDIA; HUMAN;

ADULT; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; TACHYCARDIA, VENTRICULAR;

EID: 0036517627     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Mittal SR, Mathur D. Advances in cardiac arrhythmia management. In : Das AK, editor. APICON Medicine Update (1998). Mumbai : API. 1998;298-306.
2. David Hillis L, Lange RA, Winniford MD, Page RL. Torsade de pointes and congenital long QT syndrome. In : David Hillis L, et al, editors. Manual of clinical problems in cardiology. London : Little Brown and Company. 1995;33-6.
3. Stahlmann R, Lode H. Toxicity of quinolones. Drugs 1999;58:37-42.
4. Schacht P, Arcieri G, Branolte J, et al. Worldwide clinical data on efficacy and safety of ciprofloxacin. Infection 1988;16:S29-43.
5. Schact P, Arcieri G, Hullmann R. Safety of oral ciprofloxacin. An update based on clinical trial results. Am J Med 1989;87:98S-102S.
6. Karande SC, Kshirsagar NA. Adverse drug reaction monitoring of ciprofloxacin in pediatric practice, Ind Pediatrics 1992; 9:181-8.